Clinical Trials Browser

Completed × INDUSTRY × COVID-19 × Clear all

COVID-19, Neoplasms, Korsakoff Syndrome

NCT05119855 2026-02-05

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Phase 3 Completed

165 enrolled 13 charts

COVID-19, Papillomavirus Infections

NCT06469138 2025-01-29

8479217

Phase 1 Completed

6 enrolled 17 charts

CNSDermatologicGastrointestinalMyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Mesothelioma, Malignant, COVID-19, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Myelodysplastic Syndromes, Pancreatic Neoplasms, Leukemia, Myeloid, Acute

NCT04358406 2023-11-28

Rhu-pGSN for Severe Covid-19 Pneumonia

Phase 2 Completed

64 enrolled 17 charts

Lymphoid

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Pneumonia

NCT05594147 2023-11-07

ROCURS

Completed

4,103 enrolled

COVID-19

NCT05303376 2023-09-13

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Phase 1/2 Completed

123 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular, Respiratory Aspiration

NCT04733833 2023-02-01

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

Phase 2 Completed

5 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Phase NA Completed

268 enrolled 8 charts

Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT04953234 2021-07-07

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge

Phase NA Completed

10 enrolled

COVID-19

NCT04419623 2021-05-12

A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

Phase 1 Completed

7 enrolled

Other hematologic neoplasm

COVID-19, Carcinoma, Neoplasms, Hematologic Neoplasms

NCT04564040 2020-12-29

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Phase 1 Completed

20 enrolled

Lymphoid

COVID-19, Lymphoma, Mantle-Cell

Clinical Trials

BOOST

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

8479217

Rhu-pGSN for Severe Covid-19 Pneumonia

ROCURS

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

Anti-Androgen Treatment for COVID-19

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge

A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole